No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 7.5x · 10Y median 13.6x · 15th percentile · as of Sep 11, 2026
Annualized revenue (TTM) · by quarter, last 23
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-09-29T09:30:46.347Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-09-29T09:30:46.347Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-09-29T09:30:46.347Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-09-29T09:30:46.347Z. Latest historical point 2025-09-03.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-09-29T09:30:46.347Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-09-29T09:30:46.347Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for GitLab Inc. (GTLB) stock was $46.21 as of Sep 28, 2026, 4:00 PM EDT, down 1.36% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -5.5% · 3-year avg -3.8%/yr
GitLab Inc., through its various operating entities, specializes in developing software solutions that facilitate the entire software development lifecycle. The company's operations span the United States, Europe, and the Asia Pacific regions.
Software - Application · San Francisco, CA
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-01-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Next Earnings Date
Dec 1, 2026
63 days away
EPS Estimate
0.19
Revenue Est.
$282.25M
Last Quarter Results
EPS
$0.24
vs Estimate
$0.18
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1GTLB | $7.80B | $46.21 | -1.36% | -5.53% | N/A | N/A | N/A |
| 2AAOI | $7.77B | $96.82 | -4.52% | +292.77% | +69.92% | +18.29% | vs GTLB |
| 3S | $7.66B | $22.74 | +1.63% | +6.99% | -20.88% | N/A | vs GTLB |
| 4PCTY | $7.64B | $142.72 | -0.44% | -17.62% | -11.81% | +12.83% | vs GTLB |
| 5ZETA | $7.25B | $29.00 | -1.51% | +62.09% | +34.59% | N/A | vs GTLB |
| 6IDCC | $8.44B | $327.14 | -2.12% | +8.74% | +40.58% | +19.53% | vs GTLB |
53.33
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-01-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$286.25M
vs Estimate
$273.13M
Consensus Rating
Based on 23 analysts
Average Price Target
$55.09
+19.2% upside
Low
$45.00
Current
$46.21
High
$70.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Oct 2026 | $0.20 | $0.20 | $0.21 | 15 |
| Quarter ending Jan 2027 | $0.14 | $0.19 | $0.23 | 16 |
| Quarter ending Apr 2027 | $0.22 | $0.22 | $0.23 | 12 |
| Quarter ending Jul 2027 | $0.26 | $0.26 | $0.27 | 9 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $0.85 | $0.87 | $0.88 | 15 |
| FY 2028 | $0.96 | $1.04 | $1.15 | 14 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Oct 2026 | $282.08M | $282.25M | $282.71M | 15 |
| Quarter ending Jan 2027 | $298.58M | $298.73M | $299.30M | 16 |
| Quarter ending Apr 2027 | $303.78M | $304.95M | $312.06M | 13 |
| Quarter ending Jul 2027 | $324.89M | $326.15M | $333.75M | 10 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Jan 31, 2027, matching Key Metrics.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2027 | $1.11B | $1.13B | $1.19B | 20 |
| FY 2028 | $1.29B | $1.31B | $1.34B | 19 |
